These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36089724)

  • 41. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incomplete Intestinal Obstruction Caused by a Rare Epithelioid Inflammatory Myofibroblastic Sarcoma of the Colon: A Case Report.
    Bai Y; Jiang M; Liang W; Chen F
    Medicine (Baltimore); 2015 Dec; 94(51):e2342. PubMed ID: 26705227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
    Chopra S; Maloney N; Wang WL
    Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion.
    Li X; Zheng J; Li X; Chen Y; Liu K; Li F; Lu Z
    Front Oncol; 2023; 13():1252221. PubMed ID: 37869075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A leukemoid leucocytosis].
    Cherif E; Kechaou I; Hassine LB; Boukhris I; Azzabi S; Kaouech Z; Kooli C; Khalfallah N
    Ann Biol Clin (Paris); 2012; 70(3):333-4. PubMed ID: 22565182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.
    Mansfield AS; Murphy SJ; Harris FR; Robinson SI; Marks RS; Johnson SH; Smadbeck JB; Halling GC; Yi ES; Wigle D; Vasmatzis G; Jen J
    Ann Oncol; 2016 Nov; 27(11):2111-2117. PubMed ID: 27742657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
    Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
    Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Rare Case of Incidentally Diagnosed Pulmonary Inflammatory Myofibroblastic Tumour with Dramatic Response to Crizotinib in a Postpartum Woman.
    Yorke J; Solanki K; Theegala V; Georges T; Sinha AK; Asberry DE; El Abbassi A
    Eur J Case Rep Intern Med; 2023; 10(4):003626. PubMed ID: 37051474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paraneoplastic leukemoid reaction in a patient with BRAF V600E-mutated metastatic malignant melanoma.
    Gouveia E; Sousa M; Passos MJ; Moreira A
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25576527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory fibrous histiocytoma presenting leukemoid reaction.
    Takahashi K; Kimura Y; Naito M; Yoshimura T; Uchida H; Araki S
    Pathol Res Pract; 1989 May; 184(5):498-506. PubMed ID: 2546130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelioid inflammatory myofibroblastic sarcoma: the youngest case reported.
    Batool S; Ahuja A; Chauhan DS; Bhardwaj M; Meena AK
    Autops Case Rep; 2021; 11():e2021288. PubMed ID: 34249792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Esophageal adenocarcinoma with leukemoid reaction: a case report.
    Yu G; Ji H; Meng C; Huang Y; Gao G; Liu C; Wang S; Zhang L; Ju J
    J Cardiothorac Surg; 2019 Apr; 14(1):66. PubMed ID: 30961609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pericardial Epithelioid Inflammatory Myofibroblastic Sarcoma: An Atypical Presentation.
    Azad M; Oye M; Torrente N; Mirsaeidi M
    Cureus; 2022 Jul; 14(7):e26827. PubMed ID: 35847167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
    Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
    Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukemoid reaction in the pediatric population: etiologies, outcome, and implications.
    Hoofien A; Yarden-Bilavski H; Ashkenazi S; Chodick G; Livni G
    Eur J Pediatr; 2018 Jul; 177(7):1029-1036. PubMed ID: 29696475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
    Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
    Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelioid inflammatory myofibroblastic sarcoma responsive to surgery and an ALK inhibitor in a patient with panhypopituitarism.
    Kurihara-Hosokawa K; Kawasaki I; Tamai A; Yoshida Y; Yakushiji Y; Ueno H; Fukumoto M; Fukushima H; Inoue T; Hosoi M
    Intern Med; 2014; 53(19):2211-4. PubMed ID: 25274232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paraneoplastic leukemoid syndrome in squamous cell carcinoma of the forearm.
    Das S; Shaikh OH; Prakash S; Gopal B
    BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36634990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence.
    Dukes JW; Tierney LM
    Urology; 2009 Apr; 73(4):928.e17-9. PubMed ID: 18718647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.